Today: 27 December 2025
Subscribe
Browse Tag

Johnson & Johnson

Johnson & Johnson Stock After the Bell Dec. 24, 2025: JNJ Holds Near $208 — Key News, Forecasts, and What to Watch Before the Next Market Open

Johnson & Johnson Stock After the Bell Dec. 24, 2025: JNJ Holds Near $208 — Key News, Forecasts, and What to Watch Before the Next Market Open

Johnson & Johnson (NYSE: JNJ) finished the Christmas Eve trading session higher and stayed steady after the close, with holiday-thinned volume shaping how investors should read any late-day moves. As of the latest after-hours update on Wednesday, December 24, 2025,
24 December 2025
 ·  ·  ·  · 
Johnson & Johnson Stock Today: JNJ Holds Near $207 on Dec. 24, 2025 as Talc Verdict, Drug-Price Pressure and Q4 Earnings Take Center Stage

Johnson & Johnson Stock Today: JNJ Holds Near $207 on Dec. 24, 2025 as Talc Verdict, Drug-Price Pressure and Q4 Earnings Take Center Stage

Johnson & Johnson (NYSE: JNJ) is trading through a holiday-shortened Christmas Eve session with investors balancing a familiar mix of defensive appeal and headline risk. On Wednesday, December 24, 2025, J&J shares hovered around $207 in late-morning trade, keeping the
24 December 2025
 ·  ·  ·  ·  · 
Johnson & Johnson Stock After Hours Dec. 23, 2025: JNJ Slides on Record Talc Verdict — What to Know Before Wednesday’s Open

Johnson & Johnson Stock After Hours Dec. 23, 2025: JNJ Slides on Record Talc Verdict — What to Know Before Wednesday’s Open

Johnson & Johnson (NYSE: JNJ) ended Tuesday’s session lower and traded narrowly after the closing bell as investors digested a fresh—and record-size—legal headline tied to the company’s long-running talc litigation. With U.S. markets heading into a holiday-shortened session on Wednesday,
24 December 2025
 ·  ·  ·  ·  ·  · 
Johnson & Johnson Stock (JNJ) Before the Market Opens on December 22, 2025: FDA Catalysts, Talc Litigation Headlines, Analyst Targets, and What to Watch

Johnson & Johnson Stock (JNJ) Before the Market Opens on December 22, 2025: FDA Catalysts, Talc Litigation Headlines, Analyst Targets, and What to Watch

Johnson & Johnson (NYSE: JNJ) heads into the U.S. market open on Monday, December 22, 2025, with investors balancing a familiar mix of defensive-healthcare appeal and headline-driven catalysts—from fresh talc litigation verdicts to FDA-related momentum in oncology and MedTech. Below
22 December 2025
 ·  ·  ·  ·  · 
Johnson & Johnson (JNJ) Stock Week Ahead: Drug-Pricing Politics, Talc Verdicts, and Fresh FDA Wins Set the Tone (Dec 22–26, 2025)

Johnson & Johnson (JNJ) Stock Week Ahead: Drug-Pricing Politics, Talc Verdicts, and Fresh FDA Wins Set the Tone (Dec 22–26, 2025)

As the market heads into a Christmas-shortened trading week, Johnson & Johnson (NYSE: JNJ) is entering the final stretch of 2025 with an unusually headline-heavy mix of catalysts: U.S. drug-pricing negotiations tied to the White House, new talc-related jury verdicts,
21 December 2025
 ·  ·  ·  ·  · 
Johnson & Johnson Stock After Hours Dec. 19, 2025: JNJ Ticks Up After the Bell—Key News, Forecasts, and What to Watch Before the Next Open

Johnson & Johnson Stock After Hours Dec. 19, 2025: JNJ Ticks Up After the Bell—Key News, Forecasts, and What to Watch Before the Next Open

Johnson & Johnson (NYSE: JNJ) ended Friday’s regular session lower, but the stock moved modestly higher in after-hours trading as investors digested a busy late-day news flow—ranging from Washington drug-pricing headlines to fresh analyst targets and new litigation developments. As
20 December 2025
 ·  ·  ·  ·  · 
1 2 3 4
Go toTop